Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114886652 | 11488665 | 2 | F | 20140624 | 20151105 | 20150910 | 20160816 | PER | US-ROCHE-1455366 | ROCHE | 53.00 | YR | F | Y | 0.00000 | 20160816 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114886652 | 11488665 | 1 | PS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Unknown | U | 103964 | ||||||||||
| 114886652 | 11488665 | 2 | SS | RIBASPHERE | RIBAVIRIN | 1 | Unknown | U | 0 | ||||||||||
| 114886652 | 11488665 | 3 | SS | SOVALDI | SOFOSBUVIR | 1 | Oral | U | 0 | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114886652 | 11488665 | 1 | Hepatitis C |
| 114886652 | 11488665 | 2 | Hepatitis C |
| 114886652 | 11488665 | 3 | Hepatitis C |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114886652 | 11488665 | Facial paralysis | |
| 114886652 | 11488665 | Full blood count decreased | |
| 114886652 | 11488665 | Influenza like illness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114886652 | 11488665 | 3 | 20140620 | 0 |